Data as of Oct 24
| +0.235 / +0.47%|
The 10 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 55.00, with a high estimate of 68.00 and a low estimate of 50.00. The median estimate represents a +10.62% increase from the last price of 49.72.
The current consensus among 14 polled investment analysts is to Hold stock in Integra LifeSciences Holdings Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.